Medtronic increases purchase price for Avecor
This article was originally published in Clinica
Executive Summary
Medtronic has stepped up its offer for Avecor Cardiovascular and will pay $13 in shares for each Avecor share rather than its original bid of $11.125. This price matches the offer made by another, unnamed company. Medtronic will also pay Avecor up to $10 million if the Federal Trade Commission (FTC) fails to clear the deal by March 15 1999.